Imperial Valley News Center
Anthem Foundation Joins Forces with More Than 200 Local and National Organizations To Increase Colorectal Cancer Screening Rates across the Country
Atlanta, Georgia - The American Cancer Society announced today that the Anthem Foundation has made the pledge to help increase colorectal cancer screening rates by supporting the “80 by 2018” initiative led by the American Cancer Society, the Centers for Disease Control and Prevention and the National Colorectal Cancer Roundtable.
Tim McGraw, Merck and the American Diabetes Association Challenge Americans with Type 2 Diabetes to Get to Their A1C Goal
Alexandria, Virginia - Merck and the American Diabetes Association, today announced that award-winning artist Tim McGraw, who has loved ones affected by type 2 diabetes, will travel the country to urge people with the disease to get their blood glucose under control. Together, they are launching America’s Diabetes Challenge:
American Psychological Association Marks Mental Health Awareness Month With Focus on Resilience in Children, Women, LGBT Population, Older Adults
Washington, DC - The American Psychological Association will engage a variety of audiences to raise awareness during Mental Health Awareness Month in May with the following activities:
Work, Stress, Health Conference Focuses on Role of Occupational Safety and Health in Economic Sustainability
Atlanta, Georgia - The 11th International Conference on Occupational Stress and Health: Work, Stress and Health 2015: Sustainable Work, Sustainable Health, Sustainable Organizations. Opening session plenary panel, “Comprehensively Addressing Health Challenges for Workers, Organizations and Societies through Sustainability Research and Practice,” Wednesday, May 6, 4:30 p.m. EDT, to feature:
Washington, DC - The U.S. Food and Drug Administration announced today the filing of a consent decree against Medtronic, Inc., and two of the company’s officers: S. Omar Ishrak and Thomas M. Tefft, for repeatedly failing to correct violations, related to the manufacture of Synchromed II Implantable Infusion Pump Systems, medical devices that deliver medication to treat primary or metastatic cancer, chronic pain and severe spasticity.
Washington, DC - Two drugs already on the market - an antifungal and a steroid - may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis. The study was partially funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.